Effects of soman-induced convulsions on phosphoinositide metabolism
Turnover of [3H]phosphoinositides (PI) was examined in brain slices from the hippocampus of rats undergoing soman-induced seizure activity. Hydrolysis of PI was determined by measuring the accumulation of [3H]inositol-1-phosphate (IP1). Incubation of hippocampal slices in the presence of carbachol or norepinephrine (NE) increased PI hydrolysis. Stimulated hydrolysis by NE, but not carbachol was significantly reduced in slices from soman-challenged rats undergoing convulsive activity. NE-stimulated PI hydrolysis was not reduced in slices from animals exposed to soman that did not exhibit convulsive activity. In rats surviving for 24 h, the response to NE was not different from control rats. In control slices, NE-stimulated hydrolysis of PI was potentiated by GABA. No potentiation by GABA was seen in slices from animals undergoing seizures. Uptake and incorporation ofmyo-[2-3H]inositol into phospholipids was reduced in slices from rats undergoing convulsions. Reduced IP1 production appeared to be owing, in part, to decreased synthesis of inositol lipids. These observations suggest that during soman-induced seizure activity, there is an apparent decrease in the response of the PI second messenger system to NE stimulation, and that this may contribute to the severity and duration of convulsions and brain damage resulting from exposure to soman and other anticholinesterase compounds.
Index EntriesSoman hippocampus convulsions seizures phosphoinositides inositol norepinephrine carbachol GABA
Unable to display preview. Download preview PDF.
- Baubichon D., Bourjaillat M., Kerhoas F., and Blanchet G. (1988) Effects of soman on phospholipid metabolism containing inositol in rat hippocampus.Travaux Scientifiques des Chercheurs du Service de Sante des Armees 9, 111, 112.Google Scholar
- Godfrey P. P. and Taghavi Z. (1991) The inhibition of agonist- or depolarization-evoked formation of inositol phosphate by excitatory amino acids in rat cerebral cortex is due to the neurotoxic action of this class of neurotransmitter and is mediated by sodium influx.Neuropharmacology 30, 417–422.PubMedCrossRefGoogle Scholar
- Hallcher L. M. and Sherman W. R. (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.J. Biol. Chem. 255, 10,896–10,901.Google Scholar
- Jope R. S. (1991) Activation of phosphoinositide metabolism by cholinergic agents. Contract No: DAMD17-89-C-9037. Final Report, AD #A255245.Google Scholar
- McDonough J. H. and Shih T-M. (1993) Pharmacological modulation of soman-induced seizures.Neurosci. Biobehav. Rev. 17, 2203–2215.Google Scholar
- Olney J. W., Price M. T., Zorumski C. F., and Clifford D. B. (1990) Cholinotoxic syndromes: Mechanism and protection, inProceedings of the Workshop on Convulsions and Related Brain Damage Induced by Organophosphorus Agents. US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, pp. 147–162, AD #A222912.Google Scholar
- Paulis H. and Kennedy E. P. (1960) The enzymatic synthesis of inositol monophosphatide.J. Biol. Chem. 235, 1303–1311.Google Scholar
- Shih T-M. A., Koviak T., Capacio B., and Hayward I. J. (1990) Studies of potential anticonvulsants in soman poisoning, inProceedings of the Workshop on Convulsions and Related Brain Damage Induced by Organophosphorus Agents. US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, pp. 197–221, AD #A222912.Google Scholar
- Shih T-M. A., McDonough J. H., and Koplovitz I. (1996) Evaluation of anticonvulsant drugs for soman-induced seizure activity.J. Am. Coll. Toxicol. 15(Suppl. 2), S43-S60.Google Scholar
- Shipley M. T., Nickell W. T., and El-Etri M. (1990) Mechanisms of soman-induced seizures and neuropathology, inProceedings of the Workshop on Convulsions and Related Brain Damage induced by Organophosphorus Agents. US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD. pp. 131–143, AD #222912.Google Scholar
- Wills H. (1963) Pharmacological antagonists of the anticholinesterase agents, inCholinesterases and Anticholinesterase Agents. Handbch. der Exper. Pharmakol. Erganzungsw, 15 (Koelle G.B., ed.), Springer-Verlag, Berlin, p. 884.Google Scholar